Eighteen patients with advanced tumors expressing carcinoembryonic antigen ( CEA ) were randomized to receive either recombinant vaccinia ( rV ) - CEA followed by three avipox-CEA vaccinations , or avipox-CEA ( three times ) followed by one rV-CEA vaccination .
